Non-bacterial cystitis following treatment with toripalimab for alpha-fetoprotein-producing gastric adenocarcinoma: a case report - Report - MDSpire

Non-bacterial cystitis following treatment with toripalimab for alpha-fetoprotein-producing gastric adenocarcinoma: a case report

  • By

  • Zhenpeng Li

  • Xiuxiu Yi

  • Jie Fu

  • Yan Liang

  • Sensen Zhang

  • Xv Yang

  • Zhonghai Du

  • July 14, 2026

Share

Non-infectious cystitis as a complication of toripalimab therapy in a patient with alpha-fetoprotein-producing gastric adenocarcinoma: a case study

Background

Immune checkpoint inhibitors (ICIs) have transformed the treatment landscape for gastric cancer, yet they can lead to rare immune-related adverse events (irAEs), including those affecting the urinary system. Non-bacterial cystitis is a particularly uncommon irAE, and its occurrence in patients with alpha-fetoprotein-producing gastric carcinoma (AFP-GC) is not well-documented.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

  • A 59-year-old male with AFP-GC developed non-bacterial cystitis and acute kidney injury after toripalimab and SOX chemotherapy.
  • Symptoms included urinary tract irritation, gross hematuria, and stage II acute kidney injury.
  • Cystoscopy revealed diffuse mucosal hemorrhage, and biopsy showed extensive lymphocyte infiltration and high PD-L1 expression.
  • Full-dose methylprednisolone (200 mg/day) effectively alleviated symptoms and restored renal function.

Clinical Implications

Healthcare professionals should monitor for urinary-related irAEs in patients undergoing treatment with ICIs, particularly in rare subtypes like AFP-GC.

Conclusion

This case highlights non-bacterial cystitis as a potential complication of ICI therapy in gastric cancer patients.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Author(s)/Org, Source, Year -- Title
  3. Author(s)/Org, Source, Year -- Title
  4. Author(s)/Org, Source, Year -- Title
  5. Author(s)/Org, Source, Year -- Title
  6. DailyMed - LOQTORZI- toripalimab-tpzi injection
  7. Alpha fetoprotein (AFP)-producing gastric cancer: clinicopathological features and treatment strategies
  8. Clinical presentation of PD-1/PD-L1 immune checkpoint inhibitors induced cystitis
  9. Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Living Guideline | ASCO Publications
  10. Single-center experience with immune checkpoint inhibitor-related ureteritis and cystitis
  11. Predictors of Acute Kidney Injury in Patients Prescribed Immune Checkpoint Inhibitor Therapy and Their Association with Death: A Systematic Review and Meta-Analysis: Cancer Investigation: Vol 44 , No 2 - Get Access
  12. Clinicopathological features of hepatoid adenocarcinoma and non-hepatoid adenocarcinoma of the stomach: A systematic review and meta-analysis - PubMed

Original Source(s)

Related Content